Agenda 2030

Shaping the future of hematology, together.

In 2030, the EHA community has successfully transformed hematology through innovative advancements and global collaborations.

The integration of AI and machine learning has revolutionized diagnostics and personalized care, ensuring that treatments are tailored to individual patient needs.

Equal access to medicine has been achieved, with standardized guidelines and collaborative efforts bridging gaps in healthcare quality across Europe and beyond.

The community thrives on trust, transparency, and collaboration, fostering an inclusive environment where professionals and patients alike benefit from cutting-edge research and education.

Sustainability initiatives have reduced the carbon footprint of healthcare practices, ensuring a healthier future for all.

EHA stands as a global leader, driving progress in hematology and improving the quality of life for patients worldwide.